Adalimumab 40mg/0.8mL

Adalimumab 40mg/0.8mL

Product Overview

Generic NameAdalimumab 40mg/0.8mL
Brand Name(s)Humira, Amjevita, Imraldi, Cyltezo, Hyrimoz, Hulio, Hadlima, Abrilada, Cadalimab, Idacio, Simlandi
CategoryAntibodies, monoclonal
Formsubcutaneous injection (solution)
Strength40 mg/0.8 mL
Therapeutic ClassDisease‑modifying antirheumatic drug (DMARD); immunomodulator
ATC CodeL04AB04

Manufacturing & Regulatory

ManufacturerAbbVie (Humira); Biosimilars by Amgen, Samsung Bioepis, Sandoz, Boehringer Ingelheim, Cadila (Cadalimab), Torrent
GMP ComplianceWHO‑GMP
DMF/CEPVaries by manufacturer/entity;
COFEPRISPending
Free Sale CertificateYes

Logistics & Export

MOQ10 Vials
Shelf Life24 Months
Storage2–8 °C; protect from light; do not freeze
IncotermsEXW/FOB/CIF negotiable
Lead Time7 to 10 Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Certificate of Analysis is standard from manufacturer; provided per batch
SDS-Safety Data Sheet (PDF)Manufacturer provides standard SDS (biologic/aqueous injectable)
CTD Summary (PDF)CTD modules are proprietary and require commercial purchase, often with documentation fee.